Loading…
Callan JMB Inc. is projected to decline to $1.37 by 2027, a -7% move from its current price of $1.48. CJMB is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.32 | $1.48 | $1.66 | +0.11% |
| Aug 6 | $1.26 | $1.48 | $1.75 | +0.22% |
| Aug 7 | $1.22 | $1.48 | $1.81 | +0.33% |
| Aug 8 | $1.18 | $1.49 | $1.87 | +0.44% |
| Aug 9 | $1.15 | $1.49 | $1.93 | +0.55% |
| Aug 10 | $1.12 | $1.49 | $1.98 | +0.66% |
| Aug 11 | $1.10 | $1.49 | $2.03 | +0.77% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.10 | $1.49 | $2.03 | +0.77% |
| Week 2 | $0.9749 | $1.50 | $2.32 | +1.55% |
| Week 3 | $0.8913 | $1.51 | $2.57 | +2.34% |
| Week 4 | $0.8275 | $1.53 | $2.82 | +3.13% |
| Week 5 | $0.7758 | $1.54 | $3.05 | +3.93% |
| Week 6 | $0.7323 | $1.55 | $3.28 | +4.73% |
| Week 7 | $0.695 | $1.56 | $3.51 | +5.54% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Callan JMB Inc. operates in the life sciences logistics field through its subsidiary Coldchain Technology Services, LLC, providing thermal management logistics solutions for frozen shipping in the United States. Its services cover a wide range of materials used in the life sciences sector, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities.
The company also offers emergency preparedness services, which include managing building sites, medical stockpiles of equipment and supplies, and responding to state or local emergencies; specialty temperature-regulating packaging; technical services; and advanced monitoring sentry technology. Callan JMB Inc. has a strategic partnership with Alabama State University to advance the United States pharmaceutical manufacturing and supply chain resilience.
The company was founded in 2006 and is headquartered in Spring Branch, Texas.
CJMB is currently priced at $1.35 per share, with a market capitalization of $7.62M. It holds a rank of 5159 by market cap. The near-term outlook reflects a defined price path in the forecast table, starting with a 2026 average of $1.35 and a 0% ROI, indicating a neutral stance in the near term.
A major floor 52.6% below — a decisive break under it would weaken the trend.
The nearest floor, 52.5% below — buyers have tended to step in here.
The nearest ceiling, 82.4% above — a clean break opens room to run.
A major ceiling 142.0% above — clearing it would confirm fresh momentum.
Key CJMB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CJMB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.79 | Sell | $1.63 | Sell |
| MA 10 | $1.82 | Sell | $1.64 | Sell |
| MA 20 | $1.32 | Buy | $1.44 | Buy |
| MA 50 | $0.9875 | Buy | $1.19 | Buy |
| MA 100 | $1.15 | Buy | $1.30 | Buy |
| MA 200 | $1.77 | Sell | $1.86 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.26 | Neutral |
| Stoch RSI (14) | 14.02 | Buy |
| CCI (20) | 4.00 | Neutral |
| Williams %R (14) | -68.84 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | 82.68 | Buy |
| Bollinger %B (20,2) | 0.51 | Neutral |
| Stochastic %K (14) | 31.16 | Neutral |
| TRIX (15) | 3.82 | Buy |
| Awesome (5,34) | 0.70 | Buy |
| Ultimate (7,14,28) | 49.80 | Neutral |
| Momentum (10) | 0.13 | Buy |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 1.40 | Buy |
| ADX (14) | 29.54 | Buy |
| ATR (14) | 0.18 | Info |
In the near term, the 30-day technical picture remains NEUTRAL. The RSI(14) is 50, with a SMA50 of $0.9875 and a SMA200 of $1.77, suggesting mixed momentum around the current price. Support is listed at $0.703 and resistance at $2.70, framing a modest upside from the current level.
The 30-day price range spans from a low of $0.6297 to a high of $2.89, signaling notable volatility within a relatively tight price corridor.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.702 | $1.48 | $2.04 | 0% | Neutral | |
| $0.9979 | $1.37 | $2.03 | -7% | Neutral | |
| $0.9187 | $1.34 | $2.12 | -9% | Neutral | |
| $0.8189 | $1.26 | $2.09 | -15% | Neutral | |
| $0.7086 | $1.14 | $1.98 | -23% | Bearish | |
| $0.864 | $1.46 | $2.61 | -2% | Neutral | |
| $0.9845 | $1.73 | $3.20 | +17% | Neutral | |
| $1.05 | $1.92 | $3.65 | +30% | Bullish | |
| $1.01 | $1.93 | $3.76 | +31% | Bullish | |
| $0.7381 | $1.46 | $2.92 | -1% | Neutral | |
| $1.15 | $2.56 | $5.61 | +73% | Bullish | |
| $1.51 | $3.36 | $7.72 | +127% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.702 | $1.48 | $1.81 | +0.00% |
| September 2026 | $1.26 | $1.53 | $1.94 | +3.25% |
| October 2026 | $1.33 | $1.64 | $2.12 | +7.07% |
| November 2026 | $1.29 | $1.61 | $2.11 | -1.90% |
| December 2026 | $1.21 | $1.53 | $2.04 | -4.91% |
Click any year to see its month-by-month CJMB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CJMB to range from $0.702 to $2.04 through 2026. The $1.48 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The CJMB price prediction for 2027 points to an average of $1.37 (low $0.9979, high $2.03) — a potential decline of -7% on today's $1.48. Price action looks broadly range-bound.
In 2028, CJMB is projected to trade between $0.9187 and $2.12, averaging $1.34 — a potential decline of -9% from today's $1.48. That is -2% versus the projected 2027 average. A consolidation phase looks the most probable path here.
Callan JMB Inc.'s 2029 outlook centres on $1.26, within a $0.8189 to $2.09 range. That is -6% versus the projected 2028 average. That marks a -15% change versus current levels. Price action looks broadly range-bound.
By 2030, CJMB could reach as high as $1.98, with a base case around $1.14 and support toward $0.7086 — roughly -23% from $1.48. Expect choppier, lower action through this leg of the cycle.
Expect CJMB to range from $0.864 to $2.61 through 2031. The $1.46 average target implies a -2% move from current prices. That is up +27% on the projected 2030 average. Price action looks broadly range-bound.
The CJMB price prediction for 2032 points to an average of $1.73 (low $0.9845, high $3.20) — a potential gain of +17% on today's $1.48. A consolidation phase looks the most probable path here.
In 2033, CJMB is projected to trade between $1.05 and $3.65, averaging $1.92 — a potential gain of +30% from today's $1.48. That is up +11% on the projected 2032 average. Momentum favours further upside here.
Callan JMB Inc.'s 2034 outlook centres on $1.93, within a $1.01 to $3.76 range. That is up 0% on the projected 2033 average. That marks a +31% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, CJMB could reach as high as $2.92, with a base case around $1.46 and support toward $0.7381 — roughly -1% from $1.48. Price action looks broadly range-bound.
Expect CJMB to range from $1.15 to $5.61 through 2040. The $2.56 average target implies a +73% move from current prices. That is up +75% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The CJMB price prediction for 2050 points to an average of $3.36 (low $1.51, high $7.72) — a potential gain of +127% on today's $1.48. Momentum favours further upside here.
Investing $1,000 in CJMB today (≈ 675.675676 CJMB) could be worth
$2,268.61
+$1,268.61 (+127%) by 2050 · US Dollar
Based on the average projected CJMB price of $3.36 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CJMBwould be worth at today's price.
$1,000 invested in CJMB on Jul 31, 2025 (≈ 210.084024 CJMB) would be worth
$310.92
-$689.08 (-68.9%) today · 0.31× · US Dollar
Based on a CJMB entry price of $4.76 vs. today's $1.48.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.55 | $580.39 | -42.0% |
| 1 month ago | $0.804 | $1,840.8 | +84.1% |
| 3 months ago | $1.11 | $1,333.33 | +33.3% |
| 6 months ago | $2.11 | $701.42 | -29.9% |
| 1 year ago | $4.76 | $310.92 | -68.9% |
| All time (1.5y) ago | $4.1 | $360.98 | -63.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CJMB forecast.
Our base-case forecast reaches $3.00 around 2050.
Implied market cap at $3.00: $16.94M
Across the multi-year forecast, the path is mixed but increasingly constructive after 2030. In 2030 the price is forecast to average $1.04 with a min of $0.6473 and a max of $1.81, and a bearish sentiment with a -22.7% ROI. The sequence from 2031 to 2034 shows resilience and potential upside, with 2031 avg $1.33 and 2032 avg $1.58, followed by 2033 avg $1.76 (min $0.9593, max $3.34, ROI 30.2%) and 2034 avg $1.76 (min $0.9229, max $3.43, ROI 30.3%).
By 2040 the forecast climbs to an average of $2.34 with a max of $5.12 and a 73% ROI, supported by bullish sentiment. The long-range view extends to 2050, with an average of $3.07, a max of $7.06, and a 127.2% ROI, again with bullish sentiment. These are estimates and involve notable volatility, with higher upside potential in later years while acknowledging downside risk.
Tap a question to reveal the answer.
In 2030 the forecast shows min $0.6473, avg $1.04, max $1.81, ROI -22.7, sentiment BEARISH.
Forecasts show a neutral near term (2026 avg $1.35, ROI 0%), a bear case in 2030 (avg $1.04, ROI -22.7%), followed by bullish upside in 2033/2034 and strong long-term upside (2040 avg $2.34, ROI 73%; 2050 avg $3.07, ROI 127.2%). These are estimates and not guarantees.
Yes. The forecast shows 2033 max $3.34 and 2034 max $3.43, with rising prospects into 2040 (max $5.12) and 2050 (max $7.06).
Current price is $1.35 and market capitalization is $7.62M.
For 2040 the average is $2.34 with a max $5.12 and ROI 73%; for 2050 the average is $3.07 with a max $7.06 and ROI 127.2%.
Callan JMB Inc. Community Discussion
0Share your Callan JMB Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.